# Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes

> **NCT05560971** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- PreDiabetes
- Insulin Resistance
- Overweight
- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Palmitoleic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05560971
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05560971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05560971, "Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05560971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*